Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Below historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
13.41%
↓ 62% below average
Average (34q)
35.50%
Historical baseline
Range
High:578.14%
Low:-44.99%
Volatility
1755.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 13.41% |
| Q2 2025 | 12.66% |
| Q1 2025 | 35.07% |
| Q4 2024 | -10.25% |
| Q3 2024 | -5.10% |
| Q2 2024 | 36.95% |
| Q1 2024 | -14.68% |
| Q4 2023 | 42.85% |
| Q3 2023 | -18.63% |
| Q2 2023 | 52.79% |
| Q1 2023 | -33.08% |
| Q4 2022 | -44.99% |
| Q3 2022 | 404.37% |
| Q2 2022 | -7.77% |
| Q1 2022 | 25.16% |
| Q4 2021 | 80.27% |
| Q3 2021 | 95.48% |
| Q2 2021 | 578.14% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |